Asked by: Warinder Juss (Labour - Wolverhampton West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to impose penalties on NHS Trusts who fail to tackle (a) racism and (b) racial discrimination.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Any form of racism or discrimination is unacceptable and has no place in our National Health Service.
Action is being taken to address racism and discrimination in the NHS including an urgent review of antisemitism, other forms of racism and the oversight and regulation of healthcare professionals. The review will consider how regulators address complaints of antisemitism and other forms of racism from a complaint being raised, to investigation and fitness to practice proceedings. The review will also consider how greater transparency can be brought to regulatory processes, including General Medical Council investigations and Medical Practitioners Tribunal Service decision making on antisemitism and other racism complaints.
Additionally, as set out in the 10-Year Health Plan, we will introduce a new set of staff standards for modern employment which will include reducing violence against staff and tackling racism and sexual harassment. They will underpin the NHS Oversight Framework and act as an early warning signal for the Care Quality Commission.
Asked by: Warinder Juss (Labour - Wolverhampton West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle (a) racism and (b) racial discrimination in the NHS.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Any form of racism or discrimination is unacceptable and has no place in our National Health Service.
Action is being taken to address racism and discrimination in the NHS, including an urgent review of antisemitism, other forms of racism, and the oversight and regulation of healthcare professionals. The NHS is also strengthening mandatory anti-racism training across the NHS.
Additionally, as set out in the 10-Year Health Plan, we will introduce a new set of staff standards for modern employment which will include reducing violence against staff and tackling racism and sexual harassment. They will underpin the NHS Oversight Framework and act as an early warning signal for the Care Quality Commission.
Asked by: Warinder Juss (Labour - Wolverhampton West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the proposals in the National Institute for Health and Care Excellence's final draft guidance, issued on 14 August 2025, to not recommend using cerliponase alfa, also called Brineura, for the treatment of children newly diagnosed with neuronal ceroid lipofuscinosis type 2, also called CLN2.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute of Health and Care Excellence (NICE) makes its decisions independently of the Government and in line with its carefully developed methods and processes. It would not therefore be appropriate for the Department to comment on or intervene in NICE’s decision making. However, these are very difficult decisions to make, and NICE recognises that they have real and important implications for patients. It only publishes final guidance on the use of a medicine after a very careful consideration of the evidence and a consultation with stakeholders.
NICE has not yet concluded its appraisal. It has received two appeals against its draft recommendation which will be heard by NICE’s independent appeal panel on 25 November 2025. Progress of the appraisal is available at the following link:
https://www.nice.org.uk/guidance/indevelopment/gid-hst10061
Brineura is currently available to National Health Service patients for a limited period, under a managed access agreement that was agreed in 2019. This will ensure continued access for patients who have already started treatment. It will also ensure continued access for patients who begin treatment either before the agreement ends in December or when NICE publishes its final recommendations, depending on which is sooner.
Asked by: Warinder Juss (Labour - Wolverhampton West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how the cost of redundancies during the NHS restructure will be met.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Following the Prime Minister’s announcement of the abolition of NHS England, we are clear on the need for a smaller centre, as well as scaling back integrated care board running costs and National Health Service provider corporate costs reductions in order to reduce waste and bureaucracy. Good progress is being made with the Department and NHS England having announced voluntary exit or redundancy schemes.
Provision for redundancy costs will be considered alongside the multi-year planning round.
Asked by: Warinder Juss (Labour - Wolverhampton West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will take steps to include the voices of patients in the ongoing NHS England consultation on ADHD assessments; and if he will ensure all patients have the Right to Choose.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Earlier in 2025, NHS England ran a consultation on the 2025/26 NHS Payment Scheme. This consultation was not specific to attention deficit hyperactivity disorder (ADHD) assessment services, but some concerns were raised about a perceived potential impact on ADHD services, particularly in respect of the impact on the right to choose. No changes to the legal right to choose were proposed as part of this. Following consultation, the original proposals have not been implemented.
NHS England has established an ADHD taskforce which is bringing together those with lived experience with experts from the National Health Service, education, charity, and justice sectors, to get a better understanding of the challenges affecting those with ADHD, including timely and equitable access to services and support, with the report expected in summer 2025.
The Government is also committed to patients’ legal right to choose their provider when referred to consultant-led treatment, or to a mental health professional, for their first appointment as an outpatient. This commitment is reflected in the NHS Constitution for England and the NHS Standing Rules, and is explained in the NHS Choice Framework. In addition to this, NHS England has regulatory oversight responsibilities to ensure patient choice operates effectively in the NHS.
Asked by: Warinder Juss (Labour - Wolverhampton West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential short term impact of (a) restructures of Integrated Care Systems and (b) abolition of NHS England on the ability of the NHS to deliver services.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
NHS England has asked integrated care boards (ICBs) to act primarily as strategic commissioners of health and care services and to reduce the duplication of responsibilities within their structure, with the expectation of achieving a reduction in their running cost allowance. NHS England provided additional guidance to ICBs, National Health Service trusts, and NHS foundation trusts in a letter on 1 April 2025. This letter is available at the following link:
https://www.england.nhs.uk/long-read/working-together-in-2025-26-to-lay-the-foundations-for-reform/
Along with the reform of NHS England’s responsibilities, these changes will form part of a package of measures, including the forthcoming 10-Year Health Plan, that positively impact on patient care and safety by driving quality of care, productivity, and innovation in the NHS. ICBs will continue to deliver their statutory responsibilities and NHS England’s transformation team will continue to work with ICBs to develop their plans and ensure the implementation of changes whilst maintaining a focus on delivering NHS statutory functions.